A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.

Condition:   Asthma
Interventions:   Drug: Fluticasone furoate (FF) (100 mcg);   Drug: Vilanterol (VI) (25 mcg);   Drug: Placebo
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified March 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.